1.Impact of Angiotensin Converting Enzyme Inhibitor versus Angiotensin Receptor Blocker on Incidence of New-Onset Diabetes Mellitus in Asians.
Ji Young PARK ; Seung Woon RHA ; Byoung Geol CHOI ; Se Yeon CHOI ; Jae Woong CHOI ; Sung Kee RYU ; Se Jin LEE ; Seunghwan KIM ; Yung Kyun NOH ; Raghavender Goud AKKALA ; Hu LI ; Jabar ALI ; Ji Bak KIM ; Sunki LEE ; Jin Oh NA ; Cheol Ung CHOI ; Hong Euy LIM ; Jin Won KIM ; Eung Ju KIM ; Chang Gyu PARK ; Hong Seog SEO ; Dong Joo OH
Yonsei Medical Journal 2016;57(1):180-186
PURPOSE: Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) are associated with a decreased incidence of new-onset diabetes mellitus (NODM). The aim of this study was to compare the protective effect of ACEI versus ARBs on NODM in an Asian population. MATERIALS AND METHODS: We investigated a total of 2817 patients who did not have diabetes mellitus from January 2004 to September 2009. To adjust for potential confounders, a propensity score matched (PSM) analysis was performed using a logistic regression model. The primary end-point was the cumulative incidence of NODM, which was defined as having a fasting blood glucose > or =126 mg/dL or HbA1c > or =6.5%. Multivariable cox-regression analysis was performed to determine the impact of ACEI versus ARB on the incidence of NODM. RESULTS: Mean follow-up duration was 1839+/-1019 days in all groups before baseline adjustment and 1864+/-1034 days in the PSM group. After PSM (C-statistics=0.731), a total 1024 patients (ACEI group, n=512 and ARB group, n=512) were enrolled for analysis and baseline characteristics were well balanced. After PSM, the cumulative incidence of NODM at 3 years was lower in the ACEI group than the ARB group (2.1% vs. 5.0%, p=0.012). In multivariate analysis, ACEI vs. ARB was an independent predictor of the lower incidence for NODM (odd ratio 0.37, confidence interval 0.17-0.79, p=0.010). CONCLUSION: In the present study, compared with ARB, chronic ACEI administration appeared to be associated with a lower incidence of NODM in a series of Asian cardiovascular patients.
Adult
;
Aged
;
Angiotensin Receptor Antagonists/*therapeutic use
;
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
;
Asian Continental Ancestry Group/*statistics & numerical data
;
Blood Glucose/analysis
;
Diabetes Mellitus/*diagnosis/*epidemiology
;
Dose-Response Relationship, Drug
;
Drug Monitoring/methods
;
Female
;
Follow-Up Studies
;
Humans
;
Hypertension/*drug therapy
;
Incidence
;
Kaplan-Meier Estimate
;
Logistic Models
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Propensity Score
;
Republic of Korea/epidemiology
;
Risk Factors